1177 — Sino Biopharmaceutical Cashflow Statement
0.000.00%
Last trade - 00:00- HK$43.99bn
- HK$52.34bn
- CNY26.20bn
- 90
- 56
- 20
- 58
Annual cashflow statement for Sino Biopharmaceutical, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | — |
| Source: | ARS | ARS | ARS | ARS | |
| Standards: | HKAS | HKAS | HKAS | HKAS | — |
| Status: | Final | Final | Final | Final | fx Preliminary |
| Net Income/Starting Line | 5,584 | 5,013 | 18,573 | 5,779 | — |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | -399 | -512 | -12,871 | 642 | — |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -1,393 | -786 | -1,307 | -1,163 | — |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 5,325 | 5,325 | 5,366 | 6,265 | — |
| Capital Expenditures | -1,481 | -1,495 | -1,741 | -1,403 | — |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | -2,343 | -6,350 | -775 | -2,668 | — |
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Change in Net Investments | |||||
| Purchase of Investments | |||||
| Change in Net Intangibles | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -3,824 | -7,846 | -2,516 | -4,071 | — |
| Financing Cash Flow Items | -1,512 | -1,725 | -452 | -2,014 | — |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 2,801 | 2,233 | -3,225 | -3,186 | — |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 4,396 | -7.02 | -1,025 | -945 | — |